A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
- PMID: 15550242
- DOI: 10.1016/j.cell.2004.11.022
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
Abstract
The tumor suppressor p53 gene is mutated in minimally half of all cancers. It is therefore reasonable to assume that naturally occurring polymorphic genetic variants in the p53 stress response pathway might determine an individual's susceptibility to cancer. A central node in the p53 pathway is the MDM2 protein, a direct negative regulator of p53. In this report, a single nucleotide polymorphism (SNP309) is found in the MDM2 promoter and is shown to increase the affinity of the transcriptional activator Sp1, resulting in higher levels of MDM2 RNA and protein and the subsequent attenuation of the p53 pathway. In humans, SNP309 is shown to associate with accelerated tumor formation in both hereditary and sporadic cancers. A model is proposed whereby SNP309 serves as a rate-limiting event in carcinogenesis.
Similar articles
-
A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development.Cancer Cell. 2010 Sep 14;18(3):220-30. doi: 10.1016/j.ccr.2010.07.010. Cancer Cell. 2010. PMID: 20832750 Free PMC article.
-
MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.Clin Cancer Res. 2007 Jul 15;13(14):4123-9. doi: 10.1158/1078-0432.CCR-07-0609. Clin Cancer Res. 2007. PMID: 17634539
-
A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells.Cancer Res. 2007 Mar 15;67(6):2757-65. doi: 10.1158/0008-5472.CAN-06-2656. Cancer Res. 2007. PMID: 17363597
-
Mdmx and Mdm2: brothers in arms?Cell Cycle. 2004 Jul;3(7):900-4. Epub 2004 Jul 2. Cell Cycle. 2004. PMID: 15254433 Review.
-
Polymorphic variants in the p53 pathway.Cell Death Differ. 2006 Jun;13(6):916-20. doi: 10.1038/sj.cdd.4401907. Cell Death Differ. 2006. PMID: 16557270 Review. No abstract available.
Cited by
-
Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.PLoS One. 2013;8(1):e53902. doi: 10.1371/journal.pone.0053902. Epub 2013 Jan 16. PLoS One. 2013. PMID: 23342035 Free PMC article.
-
The Pathology according to p53 Pathway.Pathobiology. 2024;91(3):230-243. doi: 10.1159/000535203. Epub 2023 Nov 14. Pathobiology. 2024. PMID: 37963443 Free PMC article. Review.
-
Identification of functional DNA variants in the constitutive promoter region of MDM2.Hum Genomics. 2012 Sep 1;6(1):15. doi: 10.1186/1479-7364-6-15. Hum Genomics. 2012. PMID: 23244604 Free PMC article.
-
MDM2 binds and inhibits vitamin D receptor.Cell Cycle. 2015;14(13):2003-10. doi: 10.1080/15384101.2015.1044176. Epub 2015 May 13. Cell Cycle. 2015. PMID: 25969952 Free PMC article.
-
Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers.BMC Cancer. 2012 Oct 5;12:454. doi: 10.1186/1471-2407-12-454. BMC Cancer. 2012. PMID: 23039163 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
